# DEXTENZA for the Treatment of Postoperative Pain and Inflammation Following Vitreo-retinal Surgery

> **NCT04462523** · PHASE4 · COMPLETED · sponsor: **Patrick R. Oellers, MD** · enrollment: 40 (actual)

## Conditions studied

- Vitreo-Retinal Surgery

## Interventions

- **DRUG:** Dextenza 0.4Mg Ophthalmic Insert
- **DRUG:** Topical Prednisolone

## Key facts

- **NCT ID:** NCT04462523
- **Lead sponsor:** Patrick R. Oellers, MD
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-03
- **Primary completion:** 2022-03-31
- **Final completion:** 2022-03-31
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2023-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04462523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04462523, "DEXTENZA for the Treatment of Postoperative Pain and Inflammation Following Vitreo-retinal Surgery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04462523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*